[1]
“ASSESSMENT OF THE RISK OF DEVELOPING ALOPECIA IN PATIENTS AFTER CORONAVIRAL INFECTIONAND EFFECTIVE TREATMENT METHODS”, ReFocus, vol. 2, no. 1, pp. 52–56, Feb. 2023, doi: 10.66073/researchfocus.v2i1.2824.